Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2167220 | Cellular Immunology | 2011 | 8 Pages |
Cholecystokinin octapeptide (CCK-8) is a neuropeptide, and is shown to be a potent immunomodulator with predominant anti-inflammatory effects. Although the regulatory effect of CCK-8 on macrophages and B cells has been defined, the effect of CCK-8 on dendritic cells (DCs) and T cells is not well understood. In this study, we showed that CCK-8 reduced the expression of CD80, CD86, and MHCII on DCs. Moreover, CCK-8 promoted Th1 and inhibited Th17 polarization by increasing the production of IL-12 and decreasing the production of IL-6 and IL-23 on DCs in vitro and in vivo. In addition, intraperitoneal administration of CCK-8 to mice with collagen-induced arthritis (CIA) was found to effectively reduce the incidence of arthritis, delay its onset and prevent the occurrence of joint damage. Collectively, these results suggest that CCK-8 significantly suppresses the incidence and severity of CIA in mice, through the inhibition of DC mediated Th17 polarization.
► The effect of cholecystokinin octapeptide (CCK-8) on DC and CD4+ T cells was investigated. ► CCK-8 reduced the expression of CD80, CD86, and MHCII on DC. ► CCK-8 promoted Th1 and suppressed Th17 polarization via modulating cytokine production on DC. ► CCK-8 effectively inhibited the progression of collagen-induced arthritis (CIA).